Surprisingly, recent findings demonstrate that CD95/CD95L support growth of tumour cells via basal activation of JNK while tissue specific deletion of CD95 reduces the incidence of liver and endometrioid ovarian cancer [19]. The gene discussed is FAS; the disease is ovarian endometrioid adenocarcinoma.